Want to receive new editions of our Newsletter straight to your inbox? Click here to subscribe!
Headlines
Upcoming webinar!
We hear a lot about ‘big data’. But how can we solve problems where we have little data? This is common when exploring new territory – for example, designing materials, chemicals, formulations, and processes. Intellegens CTO, Dr Gareth Conduit, will explore the strategies and tools needed to maximise the value gained from this data, and to guide experiment or testing along the most efficient routes as you build understanding.
13th July, 4pm UK time // 11am (US Eastern).
Additive Manufacturing solution wins ASME awards
The Intellegens Additive Manufacturing solution was a winner in the Innovation Awards at this month’s AM Tech Forum event organised by the American Society of Mechanical Engineers (ASME). Intellegens scooped the Best-in-Class Software and Startup Awards. Winners were chosen from over forty organisation presenting technical solutions at the event, a focus for the global AM community. The selection was made by a combination of expert panel review and attendee votes. The Intellegens demonstration can still be viewed at the event website. It shows how innovative deep learning methods guide AM team as they optimise processes and ensure reliable, repeatable builds.
Study validates Alchemite™ on a global pharma data set
Published in AI Letters, a new study by Optibrium, Takeda Pharmaceuticals, and Intellegens demonstrates the application of deep learning imputation to make accurate predictions of high-quality compounds on a global pharma set. The study used Alchemite™ to deliver more accurate and reliable predictions of the complex biological properties of potential drugs, enabling more effective design decisions to reduce the cost and improve the success rate of drug discovery. The work validates the technology for large, complex datasets from many different experiments, including: compound activities in biochemical and phenotypic assays; high-throughput screening data; and absorption distribution, metabolism, elimination, and toxicity (ADMET) endpoints.
Alchemite™ Focus Group shares real-world applications
Intellegens hosted the inaugural Alchemite™ Focus Group meeting this month, bringing together a diverse range of organisations to discuss how to maximise value from Alchemite™ deep learning technology as they design and optimise products and processes. Attendees joined from sectors including material production, aerospace, chemicals, formulated products, printing technology, batteries, and food & beverage. Thanks are especially due to the case study presenters from NASA, EVRAZ, and Johnson Matthey. The meeting reviewed recent developments in the Alchemite algorithm, tools for data scientists, and analytics tools. Participants were able to provide feedback and to help prioritise upcoming development work.
Recording of our recent sustainable materials webinar
If you missed our webinar on how machine learning technologies interact with digitalisation strategies, you can now view the recording online. We discussed the benefits of digitalisation, but also some of the potential pitfalls – and how the right machine learning approach both enables you to extract value early in the digitalisation process and to guide the implementation of this process m0re effectively.
Original broadcast: 23rd June 2021
We are hiring
If you know someone who would be a great fit for our team of machine learning, scientific, and software experts – get in touch. We’re currently hiring for jobs including a Product Manager, a Dev-Ops and Implementation Engineer, and a Back End Developer.
Find out more on our careers page.
For more information on how our technology can be applied to your specific needs visit https://intellegens.com or contact us at info@intellegens.com.